What were Max Healthcare Institute Ltd's latest quarterly results?
Max Healthcare Institute Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +7.2% (stable)
- Revenue Growth YoY: +12.2%
- Operating Margin: 28.0% (stable)
In , Max Healthcare Institute Ltd (Hospitals) is outperforming Nifty 500 with +6.1% relative strength. Fundamentals: Average.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +12% | +22% | Stable |
| PAT (Net Profit) | +7% | +9% | Stable |
| OPM | 28.0% | +100 bps | Stable |
Based on publicly available financial data. This is educational research, not investment advice.
Max Healthcare Institute Ltd's latest quarterly results (Mar 2026) show
Max Healthcare Institute Ltd's profit is growing with an stable trend.
Max Healthcare Institute Ltd's revenue growth trend is stable.
Max Healthcare Institute Ltd's operating margin is stable.
Max Healthcare Institute Ltd's long-term compounding rates
Max Healthcare Institute Ltd's earnings growth is stable with mixed signals on a sequential basis.
Max Healthcare Institute Ltd's trailing twelve month (TTM) performance
Max Healthcare Institute Ltd appears significantly overvalued based on our fair value analysis.
Max Healthcare Institute Ltd's current PE ratio is 73.7x.
Max Healthcare Institute Ltd's current PE is 73.7x.
Max Healthcare Institute Ltd's price-to-book ratio is 10.2x.
Max Healthcare Institute Ltd is rated Average with a fundamental score of 40.86/100. This score is calculated from objective financial metrics
Max Healthcare Institute Ltd has a debt-to-equity ratio of N/A.
Max Healthcare Institute Ltd's return ratios over recent years
Max Healthcare Institute Ltd's operating cash flow is positive (FY2026).
Max Healthcare Institute Ltd's current dividend yield is 0.18%.
Max Healthcare Institute Ltd's shareholding pattern (Mar 2026)
Max Healthcare Institute Ltd's promoter holding has decreased recently.
Max Healthcare Institute Ltd has been outperforming Nifty 500 for 1 consecutive week, indicating early-stage outperformance.
Max Healthcare Institute Ltd is a new entry this week — it just started outperforming Nifty 500. New entries are worth monitoring for follow-through.
Based on quantitative research signals, here is why Max Healthcare Institute Ltd may be worth studying
Max Healthcare Institute Ltd investment thesis summary:
Max Healthcare Institute Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.